From post

Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease

, , , , и . The New Zealand Medical Journal, 122 (1291): 48--59 (2009)PMID: 19322255.

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens, , , , , , , , , и 3 other автор(ы). Clinical and Vaccine Immunology : CVI, 14 (11): 1393–9 (ноября 2007)PMC2168176.A prospective study of the effectiveness of the New Zealand meningococcal B vaccine, , , и . American Journal of Epidemiology, 166 (7): 817--23 (октября 2007)PMID: 17615088.MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain, , , , , и . Vaccine, 23 (17-18): 2191--6 (марта 2005)PMID: 15755593.The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic, , , , , , , , , и . The New Zealand Medical Journal, 117 (1200): U1015 (августа 2004)PMID: 15475985.Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease, , , , и . The New Zealand Medical Journal, 122 (1291): 48--59 (2009)PMID: 19322255.Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine, , , , , , , , , и . The Pediatric Infectious Disease Journal, 28 (5): 385--390 (мая 2009)PMID: 19384263.